Pages that link to "Q41064279"
Jump to navigation
Jump to search
The following pages link to The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography (Q41064279):
Displaying 50 items.
- Structure-activity relationships of aminocoumarin-type gyrase and topoisomerase IV inhibitors obtained by combinatorial biosynthesis (Q24542413) (← links)
- Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase (Q24567584) (← links)
- Inhibition of archaeal growth and DNA topoisomerase VI activities by the Hsp90 inhibitor radicicol (Q24806154) (← links)
- Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187 (Q27641998) (← links)
- The Crystal Structure of the Novobiocin Biosynthetic Enzyme NovP: The First Representative Structure for the TylF O-Methyltransferase Superfamily (Q27657980) (← links)
- DNA topoisomerases and their poisoning by anticancer and antibacterial drugs (Q28284744) (← links)
- Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis (Q28345923) (← links)
- An essential role of Glu-243 and His-239 in the phosphotransfer reaction catalyzed by pyruvate dehydrogenase kinase (Q28361620) (← links)
- Marine sediment-derived Streptomyces bacteria from British Columbia, Canada are a promising microbiota resource for the discovery of antimicrobial natural products (Q28534324) (← links)
- Identification of the coumermycin A(1) biosynthetic gene cluster of Streptomyces rishiriensis DSM 40489 (Q30944562) (← links)
- Panel of Bacillus subtilis reporter strains indicative of various modes of action (Q31081404) (← links)
- Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue (Q33398170) (← links)
- Mutations in Topoisomerase IV and DNA Gyrase of Staphylococcus aureus : Novel Pleiotropic Effects on Quinolone and Coumarin Activity (Q33690598) (← links)
- Mutations in Bartonella bacilliformis gyrB confer resistance to coumermycin A1. (Q33701326) (← links)
- Gyrase inhibitors and thymine starvation disrupt the normal pattern of plasmid RK2 localization in Escherichia coli (Q33788397) (← links)
- Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. (Q34214929) (← links)
- Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein (Q34385711) (← links)
- Accumulation of mutations in both gyrB and parE genes is associated with high-level resistance to novobiocin in Staphylococcus aureus (Q34446438) (← links)
- Alteration of Escherichia coli topoisomerase IV to novobiocin resistance (Q34735901) (← links)
- Structural basis for topoisomerase VI inhibition by the anti-Hsp90 drug radicicol (Q35100607) (← links)
- All tangled up: how cells direct, manage and exploit topoisomerase function (Q35154537) (← links)
- Engineering an Antibiotic to Fight Cancer: Optimization of the Novobiocin Scaffold to Produce Anti-proliferative Agents (Q35188962) (← links)
- Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors (Q35815665) (← links)
- Mass spectrometric characterization of a three-enzyme tandem reaction for assembly and modification of the novobiocin skeleton (Q35970805) (← links)
- Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening (Q36094998) (← links)
- Modulation of drug sensitivity in yeast cells by the ATP-binding domain of human DNA topoisomerase IIalpha (Q36118901) (← links)
- Astonishing diversity of natural surfactants: 4. Fatty acid amide glycosides, their analogs and derivatives (Q36273171) (← links)
- ATP-bound conformation of topoisomerase IV: a possible target for quinolones in Streptococcus pneumoniae (Q36474350) (← links)
- TROSY in triple-resonance experiments: new perspectives for sequential NMR assignment of large proteins (Q36793550) (← links)
- Novobiocin Susceptibility of MukBEF-Deficient Escherichia coli Is Combinatorial with Efflux and Resides in DNA Topoisomerases (Q36888094) (← links)
- Purification, crystallization and preliminary X-ray crystallographic studies of the Mycobacterium tuberculosis DNA gyrase ATPase domain (Q36890089) (← links)
- Conversion of DNA gyrase into a conventional type II topoisomerase (Q37039334) (← links)
- Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis. (Q37120952) (← links)
- A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone (Q37204002) (← links)
- Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket (Q37320252) (← links)
- Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases (Q37335706) (← links)
- Thioredoxin can influence gene expression by affecting gyrase activity. (Q37509293) (← links)
- In front of and behind the replication fork: bacterial type IIA topoisomerases. (Q37694351) (← links)
- Structural and functional dissection of aminocoumarin antibiotic biosynthesis: a review (Q38014319) (← links)
- DNA gyrase can cleave short DNA fragments in the presence of quinolone drugs (Q38344294) (← links)
- Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors (Q38428349) (← links)
- DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens. (Q39078552) (← links)
- The role of monovalent cations in the ATPase reaction of DNA gyrase (Q39338697) (← links)
- Quinolone resistance mutations in the GrlB protein of Staphylococcus aureus (Q39559548) (← links)
- Probing the role of the ATP-operated clamp in the strand-passage reaction of DNA gyrase (Q39718513) (← links)
- Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance (Q39731838) (← links)
- Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin (Q39731985) (← links)
- Mutants suppressing novobiocin hypersensitivity of a mukB null mutation. (Q39775171) (← links)
- Novel whole-cell antibiotic biosensors for compound discovery (Q39810047) (← links)
- The design, synthesis, and evaluation of coumarin ring derivatives of the novobiocin scaffold that exhibit antiproliferative activity (Q39927053) (← links)